Results 41 to 50 of about 9,117 (226)
Journal of Diabetes, Volume 14, Issue 7, Page 442-454, July 2022., 2022 HighlightsNeutrophil count was an independent risk factor for CKD in patients with diabetes, especially when it exceeded 3.6 × 109/L, and increased neutrophil count could predict progression of CKD in patients with diabetes. Abstract Background This study aims to investigate the potential association of peripheral inflammatory blood cell parameters ...
Rui Zhang +12 more
wiley +1 more source
Huli yanjiu, 2002 糖尿病肾病是糖尿病（DM）常见而严重的并发症[1],行血液透析（HD）维持牛命者日益增多,但糖尿病肾病病人透析治疗比非糖尿病肾衰存活率低、并发症多,且在HD过程中经常发生一些急性并发症,所以DM病人透析有其特殊性。现就35例DM透析病人的护理总结如下。
梅晓蓉, 王绿萍, 张晓微
doaj +1 more source
Journal of Diabetes, Volume 14, Issue 6, Page 365-376, June 2022., 2022 HighlightsAssociation of lipid variability with diabetic microvascular complications. Abstract Background Greater lipid variability may cause adverse health events among diabetic patients. We aimed to examine the effect of lipid variability on the risk of diabetic microvascular outcomes among type 2 diabetes mellitus patients.
Daniel Nyarko Hukportie +6 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 5, Page 315-333, May 2022., 2022 Highlights This consensus document identifies challenging areas and strategic recommendations for the effective management of cardiorenal complications in type 2 diabetes mellitus in the Middle East and North Africa and Africa. There is a need for optimum glycemic control, early identification of cardiorenal complications, along with risk management ...
Alper Sonmez +12 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 5, Page 345-355, May 2022., 2022 Highlights Provide key information on the correlation between kidney disease measures and arterial stiffness by evaluating urine albumin‐creatinine ratio and estimated glomerular filtration rate simultaneously in a large sample with type 2 diabetes. Improving management of arterial stiffness, before reaching the chronic kidney disease stage, should ...
Chen Xu +14 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 4, Page 236-246, April 2022., 2022 Highlights Diabetic kidney disease is a progressive disease with the pathology of glomerular damage and loss of podocytes. Sodium glucose cotransporter 2 inhibitors (SGLT2i) can be expected to decrease the amount of podocyte excretion. Male patients receiving SGLT2i have better diabetic kidney disease‐related parameters and podocyturia levels. Abstract
Emre Durcan +13 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 4, Page 291-297, April 2022., 2022 Highlights C3c deposition in the kidney was associated with worse renal outcomes and was an independent predictor for ESRD in DKD patients with T2DM. C3c deposition in the kidney might be a novel biomarker indicating DKD progression in T2DM. Abstract Background Although extensive efforts have been paid to identify reliable predictors for renal outcomes
Meng‐Rui Li +6 more
wiley +1 more source
沙格列汀联合小剂量厄贝沙坦对30例早期糖尿病肾病患者预后的影响 [PDF]
, 2018 目的观察沙格列汀联合小剂量厄贝沙坦对早期糖尿病肾病患者预后的影响。方法 2017年6月—2018年3月选取该院60例早期糖尿病肾病患者为研究对象,随机分为治疗组(30例)与对照组(30例),对照组予以常规治疗+厄贝沙坦口服治疗,治疗组在对照组的基础上予以沙格列汀口服治疗,两组疗程均为3个月。检测两组患者治疗前后空腹血糖(GLU)、血清尿素氮水平、血清肌酐浓度以及瘤坏死因子-α(TNF-α)、超敏C-反应蛋白(hs-CRP)、白细胞介素-6(IL-6)炎性因子水平 ...
肖国鸣
core +1 more source
MMC celebrating 6 years of experience and expansion 庆祝MMC六年的经验和壮大
, 2022 Journal of Diabetes, Volume 14, Issue 5, Page 356-357, May 2022.
Itamar Raz
wiley +1 more source